| JYSZ2300019 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | License Renew | 2023-04-21 | | | | | view |
| JYSB2300197 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-11-14 | | | | | view |
| JYSB2300063 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-04-11 | | | | | view |
| JYSB2300016 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-02-07 | | | | | view |
| JYSB2300009 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-01-17 | | | | | view |
| JYSB2200111 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2022-06-30 | | | | | view |
| JYSB2101061 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | | | | view |
| JYSB2101013 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-04-23 | | | | | view |
| JYSB2000696 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-03-17 | view |
| JYSB2000662 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-12-24 | view |
| JYSB2000601 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-12-17 | view |
| JYSB2000387 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-10-15 | view |
| JYSB2000386 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-02 | view |
| JYSB2000140 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-05-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-01 | view |
| JYSB2000079 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-07-16 | view |
| JYSB2000034 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-02-10 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-02-18 | view |
| JYSB1900363 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-01-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-03-24 | view |
| JYSB1900081 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2019-04-11 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-12-13 | view |
| JYSB1800226 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2018-10-26 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-12-19 | view |
| JYSB1800185 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2018-08-30 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-12-19 | view |
